$6.96
0%
Price vs. AI Score (Last 150 days)
Data gathered: December 9
Data gathered: December 9
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 17 0% |
|
| Sentiment | 54 5.9% |
|
| Webpage traffic | 24,000 -1.3% |
|
| Employee Rating | 68 0% |
|
| Google Trends | -100% |
|
| Linkedin Employees | 944 N/A |
|
| Patents | 38 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 1 0% |
|
| Facebook followers | 827 0% |
|
| Stocktwits Mentions | 0% |
|
| Stocktwits Subscribers | 724 0% |
|
| Twitter Followers | 1,388 N/A |
|
| Youtube Subscribers | 1,440 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 36 0% |
|
In the news
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F18 System in Treatment of Pulmonary EmbolismDecember 7 - Finnhub |
|
Optimistic Buy Rating for AngioDynamics Supported by Trial Advancements and Market PotentialDecember 7 - TipRanks |
|
 |
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024December 7 - Yahoo |
 |
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary EmbolismDecember 6 - Yahoo |
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary EmbolismDecember 6 - Business Wire |
|
AngioDynamics completes enrollment in Acute Pulmonary Embolism Extraction trialDecember 6 - Thefly.com |
|
About Angiodynamic
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
| Price | $6.96 |
| Target Price | Sign up |
| Market Cap | $280M |
| Dividend Yield | 0.0038 |
| Industry | Medical & Dental Instruments |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$221.41 0% | 66 |
 |
DentsplyXRAY |
$31.83 0% | 51 |
 |
LeMaitre VascularLMAT |
$54.29 0% | 33 |
 |
iRhythm TechnologiesIRTC |
$88.98 0.2% | 44 |
 |
NovoCureNVCR |
$12.29 0% | 30 |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 79M | 84M | 40M | 46M | 41M |
| Q2 '23 | 90M | 103M | 46M | -21M | -13M |
| Q1 '23 | 80M | 79M | 41M | -9.5M | -1.1M |
| Q4 '22 | 85M | 82M | 45M | -8.5M | -550,000 |
| Q3 '22 | 81M | 84M | 42M | -13M | -5.8M |
Insider Transactions
| Helsel Dave filed to sell 19,189 shares at $13. February 1 '23 |
| Trowbridge Stephen A filed to buy 89,581 shares at $13.8. October 12 '22 |
| Clemmer James C filed to buy 450,407 shares at $15. October 11 '22 |
| Helsel Dave filed to sell 23,822 shares at $22.4. August 1 '22 |
Read more about Angiodynamic and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, reddit mentions, business outlook.